-
621by Peguillet, Isabelle“... of healthy donors, while in the presence of a chronic infectious disease such as HIV or tuberculosis...”
Published 2014
Get full text
-
622by Beldi-Ferchiou, Asma“... with persistent viral infection (HHV8, HIV or HCV). We show that PD-1 expression on NK cells characterizes a...”
Published 2014
Get full text
-
623by Marelli, Cecilia“... treated with P42. In the latter case, P42 was conjugated to TAT transducing peptide, derived from HIV...”
Published 2015
Get full text
-
624by Virlogeux, Victor“... transmission in the coinfected HIV-HCV French population and our results suggested that an annual DAA treatment...”
Published 2018
Get full text
-
625by Berchiche, Yamina A.“... chemokine receptor CXCR4. This receptor is an important drug target, involved in HIV-1 entry and cancer...”
Published 2011
Get full text
-
626by Nguyen, Thi Lien-Anh“... activité histone-acétyltransférase, suggérant qu’à l’instar d’autres rétrovirus tels que HIV-I ou HTLV-I...”
Published 2004
Get full text
Doctoral Thesis -
627by Berchiche, Yamina A.“..., involved in HIV-1 entry and cancer metastasis. Bioluminescence Resonance Energy Transfer (BRET) allows us...”
Published 2011
Get full text
-
628by Nguyên, Thi Liên-Anh“... histone-acétyltransférase, suggérant qu’à l’instar d’autres rétrovirus tels que HIV-I ou HTLV-I...”
Published 2004
Get full text
Others -
629by Rakotonirina, El-C Julio E. J.“... and the defaulting rate. It found that successful treatment is affected by drug resistance and co-infection TB / HIV...”
Published 2010
Get full text
Others